Ignite Creation Date:
2024-05-06 @ 3:53 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04799769
Status:
UNKNOWN
Last Update Posted:
2022-04-12
First Post:
2021-03-11
Brief Title:
Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study
Sponsor:
Vivasure Medical Limited
Organization:
Vivasure Medical Limited
Study Overview
Official Title:
Clinical Investigation Plan CIP for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study
Status:
UNKNOWN
Status Verified Date:
2022-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will be a prospective multi-centred non-randomized study to investigate the safety and performance of the PerQseal in up to 90 patients in up to 8 European investigational sites The PerQseal shall be indicated for the percutaneous closure of femoral artery punctures and to induce arterial haemostasis in patients undergoing endovascular procedures requiring an arteriotomy created with 14 - 22F sheaths arteriotomy up to 26 F
Detailed Description:
The study will be designed to be a phased study with an initial enrolment of 25 subjects in phase 1 An interim analysis may be performed after phase 1 and the remainder up to 65 subjects may be enrolled as part of phase 2
The study shall not be blinded prior to during or post the procedure All patients undergoing an endovascular procedure requiring an arteriotomy created by 14 to 22 F sheaths via the common femoral artery will be screened against the inclusionexclusion criteria If the patient meets the requirements of the clinical investigation they shall be invited to participate provide informed consent and shall subsequently be assigned a Subject Number The closure will be percutaneous An optional adjunctive endovascular balloon may be used to control bleeding All safety data from the study will be assessed by the Data Safety Monitoring Committee on a continuous basis
The Purpose of the Study is to assess safety and performance of the PerQseal Closure Device when used with the L PerQseal Introducer to percutaneously close femoral artery punctures and to induce arterial haemostasis in patients undergoing endovascular procedures requiring an arteriotomy created by 14 to 22 F sheaths
The study shall not be blinded prior to during or post the procedure All patients undergoing an endovascular procedure requiring an arteriotomy created by 14 to 22 F sheaths via the common femoral artery will be screened against the inclusionexclusion criteria If the patient meets the requirements of the clinical investigation they shall be invited to participate provide informed consent and shall subsequently be assigned a Subject Number The closure will be percutaneous An optional adjunctive endovascular balloon may be used to control bleeding All safety data from the study will be assessed by the Data Safety Monitoring Committee on a continuous basis
The Purpose of the Study is to assess safety and performance of the PerQseal Closure Device when used with the L PerQseal Introducer to percutaneously close femoral artery punctures and to induce arterial haemostasis in patients undergoing endovascular procedures requiring an arteriotomy created by 14 to 22 F sheaths
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None